Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer
Yoshinori Handa, Yasuhiro Tsutani, Noriyuki Shiroma, Yuichiro Kai, Takahiro Mimae, Yoshihiro Miyata, Yukio Takeshima, Koji Arihiro, Morihito Okada
Topics & Concepts
MedicineHazard ratioLung cancerInternal medicineCD8PD-L1OncologyImmune systemProportional hazards modelStage (stratigraphy)AdenocarcinomaImmunohistochemistryImmunotherapyTumor microenvironmentCancerGastroenterologyConfidence intervalImmunologyBiologyPaleontologyCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentImmunotherapy and Immune Responses